[13?C15] Flow diagram of requirement, allocation and follow-up of participants are given in Figure 1. Figure 1 Requirement, allocation and follow-up of participants Statistical analysis All the values in the apply for it following are the mean ?? standard deviation (SD). Significant differences between groups were determined using the paired t-test. A P-value less than 0.05 was considered to be significant. RESULTS The control group consisted of 10 males and 10 females, while the intervention group consisted of eight males and 11 females. They ranged in age from 33 to 80 years. The control group had a mean age of 57.05 ?? 12.06 years, and the intervention group had a mean age of 51.47 ?? 9.99 years. The duration over which these patients had suffered diabetes ranged from 1 to 25 years, with the mean duration of the control group being 5.
80 ?? 5.34 years and that of the intervention group being 5.21 ?? 4.88 years. All patients with type 2 diabetes take an average of two oral drugs to treat their diabetes. Of the 39 patients, 38 were on only oral hypoglycemic agents. One patient was on insulin alone, and none of the patients were on both oral hypoglycemic agents and insulin. In addition to the medications for treatment of diabetes, 12 patients were taking drugs for co-morbidities, including hyperlipidemia, hypertension and asthma. The demographic data of the study subjects are provided in Table 1. Table 1 Demographic details of study participants All the patients completed DCP at their first visit to the pharmacist, prior to any counseling.
The four subscale scores of DCP were health status, understanding, control problem and social and personal factors scales (scales I, II, III and IV) for both the AV-951 control and the intervention group patients at the baseline interview. The www.selleckchem.com/products/Belinostat.html average pre-study fasting blood glucose levels in the control and intervention groups were 150.30 ?? 40.82 mg/dL and 155.58 ?? 27.55 mg/dL, respectively. There was a slight difference between the results of the two groups during the second interview. The average fasting blood glucose of the control group during the second interview was 155.65 ?? 35.76 mg/dL, and during the final interview was 169.70 ?? 42.16 mg/dL. For the intervention group, the corresponding values were 127.63 ?? 19.07 mg/dL and 108.10 ??12.53 mg/dL, respectively.The service was able to achieve a mean reduction in the blood glucose level of 47.